News

Yahoo Finance2y
Bone Graft and Substitutes Market will reach to USD 5.78 billion by 2030 : GreyViews - Yahoo Finance
Bone Graft and Substitutes Market Size By Type (Allograft, Synthetic, Demineralized Bone Matrix (DMI), and Xenograft), By Application (Dental, Foot and Ankle, Long Bone, Craniomaxillofacial, Joint ...
Seeking Alpha2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - Seeking Alpha
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in ...
PharmiWeb2mon
Bone Graft Substitutes Market (2024-2035) - PharmiWeb.com
Market Overview. The global Bone Graft Substitutes Market is valued at USD 4.04 Billion in 2024 and is projected to reach a value of USD 8.26 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...
New Atlas2y
No bones about it: Humble eggshell may be the next bone graft material - New Atlas
We may soon be giving our unwanted eggshells to science, thanks to new research that has used the humble chicken eggshell to create a new bioactive material for making safe, effective bone grafts.
Orange County Business Journal5mon
Ventris Receives Clearance for Bone Graft Containment Technology
Previous startups he founded include Summit Surgical and Radius Medical, which was acquired by San Diego-based medical device company NuVasive Inc. in 2007 for $16 million. In 2015, Cook’s company ...
WebMD10mon
What Are Grafts for Skin, Bone, Coronary Artery Bypass, Gums, and More - WebMD
Bone Grafts. Doctors can treat damaged bone with a graft of healthy bone, usually taken from your pelvic bone on your lower back. More recently, they use injections of bone marrow instead.
ksn.com2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
WKRN-TV2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WKRN News 2
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
KELOLAND News2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - KELOLAND.com
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
WWLP-22News2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WWLP
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
WPRI 122y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WPRI.com
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...